首页> 外国专利> Sustained release of a therapeutic agent from PLA-PEG-PLA nanoparticles for cancer therapy

Sustained release of a therapeutic agent from PLA-PEG-PLA nanoparticles for cancer therapy

机译:从PLA-PEG-PLA纳米粒子持续释放治疗剂以治疗癌症

摘要

A nanoparticle that has a membrane including a polylactide-block-poly(ethylene glycol)-block-polylactide (PLA-PEG-PLA) and a polyvinyl alcohol, a bovine serum albumin contacting the membrane on the outside of the nanoparticle, a targeting group attached to the outside of the nanoparticle, and a breast cancer therapeutic agent that is encapsulated by the membrane. A nanoparticle that consists of a membrane including a polylactide-block-poly(ethylene glycol)-block-polylactide (PLA-PEG-PLA) and a polyvinyl alcohol, a bovine serum albumin contacting the membrane on the outside of the nanoparticle, breast cancer therapeutic agent that is encapsulated by the membrane, and an anti-Her2 antibody attached to the outer surface of the nanoparticle. A range of a number average molecular weight of the PEG block is 800 Da to 3 kDa and a range of a number average molecular weight of each of the PLA blocks is from 1 kDa to 5 kDa.
机译:具有包括聚丙交酯-嵌段-聚(乙二醇)-嵌段-聚丙交酯(PLA-PEG-PLA)和聚乙烯醇的膜的纳米颗粒,与该膜接触的牛血清白蛋白在纳米颗粒外侧上,靶向基团附着在纳米颗粒的外部,以及被膜包裹的乳腺癌治疗剂。纳米颗粒由包含聚乳酸-嵌段-聚(乙二醇)-嵌段-聚丙交酯(PLA-PEG-PLA)和聚乙烯醇的膜组成,牛血清白蛋白在纳米颗粒外部与膜接触,乳腺癌被膜包裹的治疗剂,和附着在纳米颗粒外表面的抗Her2抗体。 PEG嵌段的数均分子量的范围为800Da至3kDa,并且每个PLA嵌段的数均分子量的范围为1kDa至5kDa。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号